The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin

NCT03869268 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Aspirin
DRUG: Ticagrelor

Sponsor

Sheffield Teaching Hospitals NHS Foundation Trust